Lawrence Biegelsen
Stock Analyst at Wells Fargo
(0.84)
# 3,660
Out of 4,784 analysts
59
Total ratings
41.18%
Success rate
-13.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $305 → $322 | $258.75 | +24.44% | 4 | Feb 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $133 → $136 | $130.82 | +3.96% | 4 | Jan 23, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $11.85 | +68.78% | 7 | Mar 14, 2024 | |
| NVRO Nevro | Maintains: Equal-Weight | $20 → $17 | $5.84 | +191.10% | 10 | Feb 22, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $19.28 | +325.31% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $137.80 | +79.97% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $227.50 | +20.88% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $491.84 | -31.08% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $2.75 | -45.45% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $6.82 | +295.89% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $124 → $111 | $112.26 | -1.12% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $67.74 | +112.21% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $102.00 | -45.10% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $103.94 | -28.81% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $70.91 | +8.12% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $18.86 | +377.20% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $72.55 | - | 1 | Dec 12, 2019 |
Insulet
Feb 21, 2025
Maintains: Overweight
Price Target: $305 → $322
Current: $258.75
Upside: +24.44%
Abbott Laboratories
Jan 23, 2025
Maintains: Overweight
Price Target: $133 → $136
Current: $130.82
Upside: +3.96%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $11.85
Upside: +68.78%
Nevro
Feb 22, 2024
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $5.84
Upside: +191.10%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $19.28
Upside: +325.31%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $137.80
Upside: +79.97%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $227.50
Upside: +20.88%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $491.84
Upside: -31.08%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $2.75
Upside: -45.45%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $6.82
Upside: +295.89%
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $112.26
Upside: -1.12%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $67.74
Upside: +112.21%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $102.00
Upside: -45.10%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $103.94
Upside: -28.81%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $70.91
Upside: +8.12%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $18.86
Upside: +377.20%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $72.55
Upside: -